Boenisch Sandra 4
4 · ANAVEX LIFE SCIENCES CORP. · Filed Dec 23, 2024
Insider Transaction Report
Form 4
Boenisch Sandra
PFO & Treasurer
Transactions
- Award
Stock Option (Right to Buy)
2024-12-19+12,500→ 12,500 totalExercise: $5.36From: 2024-12-19Exp: 2034-02-20→ Common Stock (12,500 underlying)
Footnotes (1)
- [F1]On February 20, 2024, the reporting person was granted an option to purchase 50,000 shares of common stock. The option vests in four equal tranches based on four performance milestones, one of which was regulatory submission of AD-004 for Alzheimer's disease (US or EU). The performance criteria for this milestone was met with the acceptance of the MAA filing by the EMA, resulting in vesting of the option as to 12,500 shares.